14.07.2016
![]()
DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Dräger reports lower turnover in second quarter; EBIT on prior year level
Drägerwerk AG & Co. KGaA / Key word(s): Preliminary Results
14.07.2016 21:10
Disclosure of an inside information according to Article 17 MAR,
transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Based on preliminary figures, Drägerwerk AG & Co. KGaA recorded net of
currency effects a 0.9 percent (nominally -2.0 percent) increase in order
intake year-on-year in the second quarter of 2016. Net sales declined net
of currency effects by 6.3 percent (nominally -8.7 percent) to EUR 579.0
million. The gross margin stood at 45.5 percent (Q2 2015: 44.6 percent).
The decline in net sales was nearly offset by a reduction in functional
expenses. EBIT for the quarter stood at EUR 21.2 million, on par with the
prior-year quarter (Q2 2015: EUR 21.7 million).
For the first half of the year, this resulted in a year-on-year increase in
order intake of 0.5 percent net of currency effects (nominally -2.3
percent) and a decline in net sales by 3.3 percent net of currency effects
(nominally -5.8 percent). The gross margin was 43.8 percent (6 months 2015:
45.8 percent). Compared to the prior-year period, functional expenses
decreased net of currency effects by 5.0 percent (nominally -6.4 percent)
due to the effects of the efficiency program in the first half of 2016.
Total EBIT was EUR 5.5 million (6 months 2015: EUR 22.7 million). The EBIT
margin fell from 1.9 percent in the prior-year period to 0.5 percent.
Negative currency effects impacted the EBIT margin by roughly 2 percentage
points.
Weak demand in South America and the Middle East is primarily responsible
for the subdued business performance. Demand in many other European
countries also failed to meet the strong prior-year figures.
For fiscal year 2016, Dräger continues to expect net sales growth of
between 0.0 and 3.0 percent (net of currency effects) and an EBIT margin of
between 3.5 and 5.5 percent.
Dräger will publish its full results for the first six months of the fiscal
year on July 28, 2016.
Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23558 Lübeck, Deutschland
www.draeger.com
Investor Relations:
Thomas Fischler
Tel. +49 451 882-2685
[email protected]
Corporate Communications:
Melanie Kamann
Tel. +49 451 882-3998
[email protected]
Disclaimer
This ad hoc report contains statements on the future development of Dräger
Group. These forward-looking statements are based on the current
expectations, presumptions, and forecasts of the Executive Board as well as
the information available to date. They were compiled to the best of the
company's knowledge. Dräger does not provide any warranty nor assume any
responsibility for the future developments and results described above.
These are dependent on a number of factors. They entail various risks and
contingencies outside of the company's influence and are based on
assumptions which could prove to be incorrect. Dräger does not assume any
responsibility for updating the forward-looking statements contained in
this report. This does not infringe any legal stipulations on the
adjustment of forecasts. Please go to Investor Relations / Financial
Calendar at www.draeger.com for information on all important financial
dates.
14.07.2016 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23542 Lübeck
Germany
Phone: +49 (0)451 882-0
Fax: +49 (0)451 882-2080
E-mail: [email protected]
Internet: www.draeger.com
ISIN: DE0005550602, DE 000 555 063 6, DE 000 555 065 1, DE 000 555
067 7, DE 000 555 071 9
WKN: 555060, 555063 Vorzüge, 555065 Genussschein A, 555067 Genussschein K, 555071 Genussschein D
Indices: TecDAX
Listed: Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime
Standard), Hamburg, Hanover, Munich; Regulated Unofficial
Market in Stuttgart; Terminbörse EUREX
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
|
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu
Drägerwerk AG & Co. KGaA ISIN: DE0005550602 können Sie bei EQS abrufen
Medtech , 555060 , DRW8 , XETR:DRW8